Special Seminar: Dr. Peter Krulevitch, "Innovation Within a Large Medical Device Company: a Journey from Microtechnology R&D to User Needs Driven Design"

Jose Padovani josep at stanford.edu
Wed Feb 22 20:20:49 PST 2012

Special Seminar 

Innovation Within a Large Medical Device Company: a Journey from Microtechnology R&D to User Needs Driven Design

Dr. Peter Krulevitch
Research Fellow, Janssen R&D 

Tuesday, February 28, 2012
Allen 101X Auditorium

Over the past ten years, the R&D environment inside large medical device companies has changed considerably, making it increasingly challenging to develop innovative products from within. Spending on early development projects has declined, including an end to funding for projects not directly tied to product launches. At the same time, the allowable time before R&D innovations must impact sales has decreased. As a result, the model for driving internal innovation has evolved. This presentation will cover one engineer’s R&D experience at Johnson & Johnson over a period of nearly ten years. Initial efforts focused on the application of microtechnology to medical devices, including Nitinol thin films aimed at cardiovascular applications and electrokinetic patch pumps for drug delivery. Mid-­‐term projects applied low risk microtechnology with increased attention to user needs, emphasis on industrial design as well as technology, and focus and accountability for near term results. Projects included insulin infusion sets and subcutaneous sensor inserters with flexible etched Nitinol/polymer hybrid needles, injection molded micropumps with etched valves for drug delivery, and drug delivery management systems. Recently, efforts have drifted away from technology-­‐based innovation in favor of patient-­‐centric design-­‐based innovation, focusing on simple, intuitive to use devices. An example of a self-­‐administration device for subcutaneous injections will be presented. 

Short Bio:
Peter Krulevitch is a Research Fellow at Janssen R&D, the pharmaceutical development organization within Johnson & Johnson, where he leads a small team responsible for early development of devices for subcutaneous, intramuscular, intravenous, intranasal, and pulmonary delivery of large and small molecule drugs. He joined Janssen from J&J’s device sector, where he led a group focused on applying microtechnology to medical devices, and worked with LifeScan and Animas on devices for the treatment of diabetes. Prior to J&J, he was a Research Engineer at Lawrence Livermore National Laboratory’s Center for Microtechnology, where he worked on microfluidic systems for cell-based diagnostics and flexible electrode arrays for retinal implants, among other projects. He received his Ph.D. in Mechanical Engineering from UC Berkeley (1994), where he studied the mechanical properties of polycrystalline silicon at the Berkeley Sensor & Actuator Center with Professors Roger Howe and George Johnson. Dr. Krulevitch is co-inventor on approximately 50 issued patents. 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://snf.stanford.edu/pipermail/labmembers/attachments/20120222/a0df9267/attachment.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: PeterKrulevitch_Seminar.Feb28.2012.pdf
Type: application/pdf
Size: 68410 bytes
Desc: not available
URL: <http://snf.stanford.edu/pipermail/labmembers/attachments/20120222/a0df9267/attachment.pdf>
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://snf.stanford.edu/pipermail/labmembers/attachments/20120222/a0df9267/attachment-0001.html>

More information about the labmembers mailing list